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The Country Health Profile series
The State of Health in the EU’s Country Health Profiles 
provide a concise and policy-relevant overview of 
health and health systems in the EU/European Economic 
Area. They emphasise the particular characteristics and 
challenges in each country against a backdrop of cross-
country comparisons. The aim is to support policymakers 
and influencers with a means for mutual learning and 
voluntary exchange.
The profiles are the joint work of the OECD and the 
European Observatory on Health Systems and Policies, 
in cooperation with the European Commission. The team 
is grateful for the valuable comments and suggestions 
provided by the Health Systems and Policy Monitor 
network, the OECD Health Committee and the EU Expert 
Group on Health Systems Performance Assessment (HSPA).
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Data and information sources
The data and information in the Country Health Profiles 
are based mainly on national official statistics provided 
to Eurostat and the OECD, which were validated to 
ensure the highest standards of data comparability. 
The sources and methods underlying these data are 
available in the Eurostat database and the OECD health 
database. Some additional data also come from the 
Institute for Health Metrics and Evaluation (IHME), the 
European Centre for Disease Prevention and Control 
(ECDC), the Health Behaviour in School-Aged Children 
(HBSC) surveys and the World Health Organization 
(WHO), as well as other national sources.  
The calculated EU averages are weighted averages of 
the 27 Member States unless otherwise noted. These EU 
averages do not include Iceland and Norway.
This profile was completed in September 2021, based on 
data available at the end of August 2021.
Demographic factors Ireland EU
Population size (mid-year estimates) 4 964 440 447 319 916
Share of population over age 65 (%) 14.4 20.6
Fertility rate¹ (2019) 1.7 1.5
Socioeconomic factors
GDP per capita (EUR PPP²) 63 811 29 801
Relative poverty rate³ (%, 2019) 13.1 16.5
Unemployment rate (%) 5.7 7.1
1. Number of children born per woman aged 15-49. 2. Purchasing power parity (PPP) is defined as the rate of currency conversion that equalises the 
purchasing power of different currencies by eliminating the differences in price levels between countries. 3. Percentage of persons living with less than 60 % 
of median equivalised disposable income. Source: Eurostat database.
Disclaimer: The opinions expressed and arguments employed herein are solely those of the authors and do not necessarily reflect the official views of 
the OECD or of its member countries, or of the European Observatory on Health Systems and Policies or any of its Partners. The views expressed herein 
can in no way be taken to reflect the official opinion of the European Union.
This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation 
of international frontiers and boundaries and to the name of any territory, city or area.
Additional disclaimers for WHO apply.
© OECD and World Health Organization (acting as the host organisation for, and secretariat of, the European Observatory on Health Systems and 
Policies) 2021 
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People in Ireland lead longer and healthier lives than most other Europeans, although behavioural risk factors, 
including smoking and obesity, remain important public health concerns. Quality of health care is generally good, 
but access to services is constrained by costs and waiting times. The COVID-19 pandemic exposed health system 
weaknesses – in particular a shortage of health workers in the public sector and low intensive care unit capacity 
in public hospitals. It also revealed some of Ireland’s strengths in responding to crises, including the ability to 
develop technological solutions and to mobilise additional funding rapidly for health reform, health workforce 
and hospital resources. 
Health Status
Life expectancy in Ireland has increased rapidly since 2000, reaching 
82.8 years in 2019, 1.5 years higher than the EU average. Circulatory 
diseases and cancers remain the leading causes of death, accounting for 
more than 30 % of all deaths.
Risk factors 
Behavioural risk factors are a major driver of mortality in Ireland. While 
smoking rates among adults have reduced, obesity among adults is on the 
rise and is now slightly higher than the EU average. One quarter of adults 
in Ireland report regular heavy alcohol consumption, which is also above 
the EU average.
Health system
Spending on health per capita in Ireland is close to the EU average. Public 
coverage of spending for inpatient care is more limited than in other EU 
countries, while it is greater for pharmaceuticals. The majority of the 
population pays the full cost of general practitioner visits, outpatient 
prescriptions up to monthly thresholds, outpatient medical supplies and 
dental care. Spending on prevention was below the EU average in 2019 but 
saw a substantial increase in response to COVID-19.
 
Effectiveness
Mortality from preventable and 
treatable causes in Ireland is 
lower than in most EU countries. 
Still, there is room for further 
progress to reduce premature 
deaths through public health 
interventions and more timely 
diagnosis and treatment.
Accessibility
COVID-19 has affected access to 
care in Ireland: one fifth of the 
population reported unmet needs 
for medical care and treatment 
in 2020. Use of teleconsultations 
during the first wave of the 
pandemic aimed to improve 
access, and uptake was greater 
than the EU average.
Resilience 
Ireland’s successful management 
in the early phases of the 
COVID-19 pandemic was 
challenged in late 2020 a severe 
third wave was experienced. By 
the end of August 2021, Ireland’s 
vaccination programme achieved 
above EU average results, with 
almost 70 % of the total population 
receiving two doses (or equivalent).
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Option 1: Life expectancy - trendline Select a country:
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Effectiveness - Preventable and treatable mortality Select country
Country code Country Preventable Treatable
AT Austria 157 75 Treatable mortality
BE Belgium 146 71 Preventable mortality
BG Bulgaria 226 188
HR Croatia 239 133
CY Cyprus 104 79 For translators ONLY:
CZ Czechia 195 124
DK Denmark 152 73
EE Estonia 253 133
FI Finland 159 71
FR France 134 63
DE Germany 156 85
GR Greece 139 90
HU Hungary 326 176
IS Iceland 115 64
IE Ireland 132 76
IT Italy 104 65
LV Latvia 326 196
LT Lithuania 293 186
LU Luxembourg 130 68
MT Malta 111 92
NL Netherlands 129 65
NO Norway 120 59
PL Poland 222 133


























Age-standardised mortality rate per 100 000 
Share of total population vaccinated against 
COVID-19 up to the end of August 2021
Share of total population vaccinated against COVID-19
Note: Up to end of August 2021  
Source: Our World in Data.
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2 Health in Ireland
Life expectancy in Ireland has increased by 
more than six years since 2000
Life expectancy at birth in Ireland has increased 
rapidly since 2000 to reach 82.8 years in 2019, which is 
1.5 years above the EU average (Figure 1). Most gains 
in life expectancy occurred between 2000 and 2010. 
These gains slowed following the economic crisis, as 
in other European countries, although life expectancy 
increased by 2 years between 2010 and 2019. 
In 2019, the gap in life expectancy between men 
and women was nearly 4 years (80.8 years for men 
compared to 84.7 years for women), less than the EU 
average of 5.5 years.
Figure 1. Life expectancy in Ireland has increased rapidly and is among the highest in the EU
 
Note: The EU average is weighted. 
Source: Eurostat Database.
Ischaemic heart disease remains the leading 
cause of death, but COVID-19 led to many 
deaths in 2020
In 2018, circulatory diseases and cancers accounted 
for more than 30 % of all deaths in Ireland. More 
specifically, ischaemic heart disease was the leading 
cause of mortality in 2018 (accounting for nearly 
14 % of all deaths), followed by lung cancer (the 
most frequent cause of death by cancer), chronic 
obstructive pulmonary disease (COPD) and stroke 
(Figure 2).
In 2020, COVID-19 accounted for 2 259 deaths in 
Ireland (7.0 % of all deaths in 2018), mainly among 
older people. An additional 2 800 COVID-19 deaths 
were registered in the first eight months of 2021. 
By the end of August 2021, the mortality rate from 
COVID-19 was about one third lower in Ireland than 
the average across EU countries (about 1 025 deaths 
per million population compared to 1 590 for the EU 
average).
Life expectancy at birth, 2000, 2010 and 2020
Select a country:
GEO/TIME 2000 2010 2019 2000 2010 2019
Spain 79.3 82.4 84.0 0 #N/A #N/A #N/A
Italy 79.9 82.2 83.7 0 #N/A #N/A #N/A
Iceland 79.7 81.9 83.2 0 #N/A #N/A #N/A
Sweden 79.8 81.6 83.2 0 #N/A #N/A #N/A
France 79.2 81.8 83.0 0 #N/A #N/A #N/A
Norway 78.8 81.2 83.0 0 #N/A #N/A #N/A
Malta 78.5 81.5 82.9 0 #N/A #N/A #N/A
Ireland 76.6 80.8 82.8 1 76.6 80.8 82.8
Luxembourg 78.0 80.8 82.7 0 #N/A #N/A #N/A




















































































































































Figure 2. COVID-19 accounted for 7 % of deaths in 2020
Note: The number and share of COVID-19 deaths refer to 2020, while the number and share of other causes refer to 2018. The size of the COVID-19 box is 
proportional to the size of the other main causes of death in 2018. 
Sources: Eurostat (for causes of death in 2018); ECDC (for COVID-19 deaths in 2020, up to week 53).
Most Irish people report being in good health, 
but nearly three in ten have a chronic condition
In 2019, 84 % of the population reported being in good 
health – the highest proportion in the EU. However, 
as in other countries, disparities between income 
groups are clear: 93 % of the Irish population in the 
highest income quintile reported being in good health, 
compared with 72 % of those in the lowest (Figure 3).
Nearly three in ten Irish adults (28 %) reported having 
at least one chronic condition in 2019 – a proportion 
below the EU average (36 %), according to EU-SILC. 
This proportion increases with age: more than half 
of Irish people aged 65 and over reported having at 
least one chronic condition. Many of these conditions 
increase the risk of severe complications from 
COVID-19. As with self-reported health, there is a gap 
in the prevalence of chronic conditions by income 
group: 42 % of Irish adults in the lowest income 
group report having at least one chronic condition, 
compared with 17 % among those in the highest.
Figure 3. Ireland has the highest share of self-
reported good health in the EU
 
Note: 1. The shares for the total population and the low-income 
population are roughly the same. 
Source: Eurostat Database, based on EU-SILC (data refer to 2019).
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The burden of cancer in Ireland is higher than 
the EU average
According to estimates by the Joint Research Centre 
based on incidence trends from previous years, an 
estimated 27 000 new cancers were expected in 
Ireland in 20201, and the age-standardised incidence 
rate was expected to be the highest in the EU for both 
men and women (Figure 4). The main cancer sites 
among men are prostate (31 %), colorectal (13 %) and 
lung (11 %), while among women these are breast 
(27 %), lung (13 %) and colorectal cancer (10 %). The 
1. It should be noted that these estimates were made before the COVID-19 pandemic; this may have an effect on cancer incidence during 2020.
high and increasing incidence of cancers is attributed 
in part to the ageing population and behavioural risk 
factors – in particular, smoking, alcohol consumption 
and low physical activity (see Section 3).
In 2018, over 31 000 people died from cancer. The 
age-standardised mortality rate from cancer was 
close to the EU average (270 per 100 000 population). 
Ireland’s National Cancer Strategy 2017-26 identified 
cancer prevention and optimisation of care among 
priority improvement areas (see Section 5.1).
Figure 4. The most frequently diagnosed cancers in 2020 were expected to be prostate and breast cancers
Note: Non-melanoma skin cancer is excluded; uterus cancer does not include cancer of the cervix. 
Source: ECIS – European Cancer Information System.
3 Risk factors
Behavioural risk factors are a major driver of 
mortality
Over 35 % of all deaths in Ireland in 2019 could be 
attributed to behavioural risk factors, such as tobacco 
smoking, dietary risks, alcohol consumption and low 
physical activity (Figure 5). Some 20 % were related to 
tobacco smoking (including direct and second-hand 
smoking) – a share larger than the EU average (17 %). 
Dietary risks (including low fruit and vegetable intake, 
and high sugar and salt consumption) were estimated 
to account for about 13 % of all deaths in Ireland, 
which is lower than the EU average. 
 
About 5 % of all deaths can be attributed to alcohol 
consumption, while about 3 % of all deaths are 
related to low physical activity. Albeit to a lower 
extent than in other EU countries, environmental 
issues in Ireland, such as air pollution in the form of 
fine particulate matter (PM2.5) and ozone exposure, 
also had a significant impact on mortality and were 
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14 378 new cases
Age-standardised rate (all cancer)
IE: 822 per 100 000 population
EU: 686 per 100 000 population
Age-standardised rate (all cancer)
IE: 631 per 100 000 population
EU: 484 per 100 000 population
Women
12 689 new cases





Figure 5. Tobacco and dietary risks are major contributors to mortality in Ireland
Note: The overall number of deaths related to these risk factors is lower than the sum of each one taken individually, because the same death can be 
attributed to more than one risk factor. Dietary risks include 14 components such as low fruit and vegetable intake, and high sugar-sweetened beverages 
consumption. Air pollution includes exposure to PM2.5 and ozone alone. 
Sources: IHME (2020), Global Health Data Exchange (estimates refer to 2019).
2. Based on measured data of the actual weight and height of people, which is a more reliable measure, the obesity rate is even higher in Ireland but has remained 
stable at 23 % between 2007 and 2019.
3. Binge drinking is defined as consuming six or more alcoholic drinks on a single occasion for adults.
Smoking rates among adults in Ireland are 
below the EU average
Ireland made substantial progress over the past two 
decades in reducing smoking rates: one in seven Irish 
adults (14 %) smoked daily in 2019 compared to more 
than one in four (27 %) in 2002. The rate in 2019 was 
below the EU average, but still slightly higher than 
that registered in several Nordic countries (Figure 6). 
However, use of e-cigarettes has become more 
popular. In 2019, 5 % of the Irish population reported 
using e-cigarettes – up from 3 % in 2015 (Department 
of Health, 2019). Tobacco smoking has also become 
less popular among adolescents. Only about 10 % of 
15-year-olds in Ireland reported that they had smoked 
cigarettes in the past month in 2018, which is one of 
the lowest rates in the EU. 
Overweight and obesity among adults represent 
growing public health issues in Ireland
Based on self-reported data, overweight and obesity 
rates have increased in recent years among adults 
in Ireland. The rate of obesity increased from 15 % 
in 2007 to 18 % in 2015, and is above the EU average 
(16 %)2. Among adolescents, 14 % of 15-year-olds were 
overweight or obese in 2018 – a share lower than in 
most EU countries. 
Low physical activity contributes to overweight and 
obesity. Only about one in six 15-year-olds reported 
doing at least moderate physical activity each day 
in 2018 – a proportion similar to many other EU 
countries. On a more positive note, adults in Ireland 
are more physically active than in most EU countries. 
In 2014, rates of physical inactivity among adults were 
27 % in Ireland, compared to the EU average of 36 %. 
Fruit and vegetable consumption among adults and 
adolescents are also among the highest across EU 
countries. 
Heavy alcohol consumption is an important 
risk factor in Ireland
Nearly one quarter of adults (24 %) in Ireland reported 
regular heavy alcohol consumption (binge drinking3) 
in 2019 – a higher proportion than most EU countries. 
Rates of binge drinking are more than twice as high 
for men than women. Consumption per adult was 
10.8 litres of pure alcohol in 2019, nearly 10 % higher 
than the EU average. 
Heavy alcohol consumption among 15-year-olds 
is, however, less widespread in Ireland than across 
the EU. Only 15 % of 15-year-olds reported that 
they had been drunk at least twice in their life in 
2018, compared with a 22 % EU average (Figure 6). 
Nonetheless, further progress could be achieved in 
reducing early drinking initiation and this is a core 
objective of Ireland’s Public Health (Alcohol) Act 
introduced in 2018. The legislation was an important 
development in alcohol control policy to curb trends, 
introducing minimum unit pricing and structural 
separation of alcohol products in mixed retail 
outlets, among other provisions that target restricting 
access to alcohol products by children. However, key 
elements of this legislation are yet to be implemented 
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Figure 6. Adult obesity and alcohol consumption are important public health concerns in Ireland
Note: The closer the dot is to the centre, the better the country performs compared to other EU countries. No country is in the white “target area” as there is 
room for progress in all countries in all areas. 
Sources: OECD calculations based on HBSC survey 2017-18 for adolescents indicators; and EHIS 2014, EHIS 2019 and national source for adults indicators.
4 The health system
4. Given that a significant proportion of the GDP in Ireland consists of profits from foreign-owned companies that are repatriated, gross national income (GNI) is a 
more meaningful measure of the capacity to pay for health care in Ireland.
5. OOP payments include direct payments, cost-sharing for services outside the benefit package and informal payments.
Ireland has a national health service, but 
many people also purchase voluntary health 
insurance
Ireland has a national health service, funded 
primarily through general taxation. Almost half the 
population nevertheless purchase private voluntary 
health insurance (VHI), primarily to obtain faster 
access to care for diagnostics, appointments with 
specialists and elective hospital treatment.
The Department of Health is responsible for 
providing leadership, policy direction, governance 
and performance oversight for the health sector, and 
for allocating the health budget. Management and 
delivery of publicly funded health and social care 
services are delegated to the Health Service Executive 
(HSE), a government agency under the oversight of the 
Department of Health. Both the Department of Health 
and the HSE played a central role in coordinating 
Ireland’s COVID-19 pandemic response (Box 1). 
The HSE provides health and social care through 
its own network of providers, including hospitals 
and community health organisations. A purchaser–
provider split is operationalised when the HSE 
purchases care from private providers (including 
general practitioners (GPs) and nursing homes) and 
not-for-profit public hospitals, or when voluntary 
health insurers pay for care in public facilities.
Most health spending is financed through 
taxation, but voluntary health insurance also 
plays a large role
Per capita health spending in Ireland was EUR 3 513 
in 2019 (adjusted for purchasing power), which is 
close to the EU average (Figure 7). Health spending as 
a share of GDP was 6.7 % in 2019, but reached 11.1 % 
when measured against gross national income4 (CSO, 
2019). 
Revenues for health are predominantly raised through 
general taxation, supplemented by a universal social 
charge levied on employees and self-employed 
workers. Government financing accounted for 75 % 
of total health expenditure in 2019 – a relatively 
low share compared to the EU average of 80 %. The 
share of health spending from out-of-pocket (OOP) 
payments5 in 2019 was 11.7 %, which is below the EU 
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Figure 7. Per capita health spending in Ireland is close to the EU average
 
 
Note: The EU average is weighted. 
Source: OECD Health Statistics 2021 (data refer to 2019, except for Malta and Iceland 2018).
Spending on inpatient care and long-term care 
in Ireland is relatively high
Inpatient care was the largest category of health 
spending in Ireland in 2019, accounting for one third 
of the total (Figure 8). A quarter of health spending 
was allocated to outpatient care – the fourth lowest 
share in the EU. Per capita spending on long-term care 
was 20 % higher than the EU average. In contrast, per 
capita spending on outpatient pharmaceuticals and 
medical devices was 27 % lower than the EU average.
 
Spending on prevention in 2019 was below the EU 
average, but Ireland increased funding allocated 
to prevention activities and other health sector 
functions during the COVID-19 pandemic (Box 2).
Box 1. Ireland responded to COVID-19 with a public health-led, whole-of-government approach
Ireland’s response to COVID-19 was centrally 
coordinated, with national leadership provided by 
the Department of the Taoiseach (Prime Minister), 
in collaboration with the Department of Health 
and HSE. A National Public Health Emergency 
Team for COVID-19 was formed in January 2020, 
chaired by the Chief Medical Officer and comprising 
more than 30 medical, scientific and health service 
professionals and experts. The Team is supported 
by a multidisciplinary Coronavirus Expert Advisory 
Group and 10 subgroups that focus on areas including 
epidemiological modelling, vulnerable groups, acute 
hospital preparedness, medicines and health care 
workers (see Section 5.3).
The Team also works closely with the HSE National 
Crisis Management Team and Crisis Communications 
Group. A trans-partisan Special Cabinet Committee 
on COVID-19 chaired by the Taoiseach and supported 
by government officials from all departments 
and other agencies was also formed to ensure 
implementation of a whole-of-government response.
Sources: COVID-19 Health Systems Response Monitor; Kennelly et al. (2020); Government of Ireland (2020a).
Country Government & compulsory insurance schemes Voluntary  insurance & out-of-pocket payments Total Exp. Share of GDP
Norway 4000 661 4661 10.5
Germany 3811 694 4505 11.7
Netherlands 3278 689 3967 10.2
Austria 2966 977 3943 10.4
Sweden 3257 580 3837 10.9
Denmark 3153 633 3786 10.0
Belgium 2898 875 3773 10.7
Luxembourg 3179 513 3742 5.4
France 3051 594 3645 11.1
EU27 2809 714 3521 9.9
Ireland 2620 893 3513 6.7
Finland 2454 699 3153 9.2
Iceland 2601 537 3138 8.5
Malta 1679 966 2646 8.8
Italy 1866 659 2525 8.7
Spain 1757 731 2488 9.1
Czechia 1932 430 2362 7.8
Portugal 1411 903 2314 9.5
Slovenia 1662 621 2283 8.5
Lithuania 1251 633 1885 7.0
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The proportion of expenditure from VHI schemes 
was 14 %, which is the second highest in the EU after 
Slovenia, and almost three times higher than the EU 
average (4.9 %). In Slovenia, VHI is primarily used to 
cover co-payments and plays a complementary role, 
whereas in Ireland it is supplementary, providing 
people with faster access to care and some cover for 
co-payments. 





Figure 8. Spending on prevention and pharmaceuticals and medical devices is lower than EU averages
Note: The costs of health system administration are not included. 1. Includes curative-rehabilitative care in hospital and other settings; 2. Includes home care 
and ancillary services (e.g. patient transportation); 3. Includes only the health component; 4. Includes only the outpatient market; 5. Includes only spending 
for organised prevention programmes. The EU average is weighted. 
Sources: OECD Health Statistics 2021, Eurostat Database (data refer to 2019).
 
Coverage for publicly funded health care in 
Ireland is not universal
Ireland does not offer universal entitlement to public 
health care. The population is divided into two main 
entitlement categories: category I – those who qualify 
for medical cards (32 % of the population in 2021) and 
category II – those without medical cards (McGlacken-
Byrne, Parker & Burke, 2021).
Category I medical cardholders are primarily 
determined on the basis of income through means-
testing. A small number of people obtain discretionary 
medical cards on the basis of “undue hardship”, 
no matter their income. People with medical cards 
have access to free primary and hospital care 
and minimum dental care without charge. They 
do, however, pay a prescription charge or levy of 
EUR 1.50 per item (EUR 1.00 for people over 70), up 
to a maximum of EUR 15 (EUR 10 for people over 
70) per month per capita or family. Asylum seekers 
are entitled to the same range of health services as 
category I card holders.
Box 2. Ireland committed a record amount of funding to the health sector during the pandemic
Just under EUR 5 billion in additional funding was 
allocated to the health sector in Ireland during the 
COVID-19 crisis to support the pandemic response 
and to help address longstanding systemic issues. 
In March 2020, EUR 435 million was allocated to 
support the HSE in strengthening public capacity 
for testing and contact tracing; freeing up bed 
space in hospitals by purchasing additional bed 
space from private hospitals; increasing the health 
workforce and National Ambulance Service capacity; 
centralising procurement of medical technologies; and 
supporting remote monitoring of patients and remote 
consultations.
The Winter Initiative in September 2020 saw an 
additional EUR 600 million committed to the health 
service, to ensure it had the capacity and resources 
to continue responding effectively to COVID-19 
during the winter months. EUR 4 billion was later 
committed in the 2021 budget (Department of 
Health, 2020). Approximately EUR 1.6 billion is for 
COVID-19 expenditure, with more than half allocated 
for substantial development of health and social 
care services, in line with Ireland’s Sláintecare reform 
programme, which aims to deliver universal health 
coverage (see Section 5.2). This places emphasis on 
strengthening the public health workforce – including 
public health doctors, nurses, scientists and support 
staff – as an investment in the future development 
of public health in Ireland.
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Two other schemes provide additional benefits. One 
is a “GP visit card”, which covers GP charges but not 
medicines for all children under 6, adults over 70 and 
some people on low incomes: the income threshold 
to obtain it is higher than the medical card threshold. 
As of 2021, around 10 % of the population had GP 
visit cards (McGlacken-Byrne, Parker & Burke, 2021). 
The second is the Long-Term Illness Scheme, which 
provides free medicines and appliances for people 
living with certain chronic conditions, regardless of 
income. 
The majority of the population is not covered by 
a medical card, a GP visit card or the Long-Term 
Illness Scheme, and must pay the full cost of GP 
visits, outpatient prescriptions (up to monthly 
thresholds), outpatient medical supplies and dental 
care. Care in public hospitals in Ireland is provided 
free of charge or at reduced cost for all residents. 
However, extremely long waiting lists and waiting 
times in the public system and user charges mean 
that many people buy VHI to receive expedited access 
to hospital care and diagnostics, creating a de facto 
two-tier health care system (see Section 5.2). This 
context is partly responsible for many inequalities 
in the Irish health care system, which are addressed 
by the Sláintecare reform programme and its aim of 
universal health care. 
People in category II are subject to co-payments for 
primary and hospital care (see Section 5.2). Primary 
care user charges include fees per GP visit (EUR 40-60 
per visit) (Johnston, Thomas & Burke, 2020), with no 
annual cap – a situation that is exceptional in western 
Europe. For inpatient services, a charge of EUR 80 
per day is applied, up to a maximum of EUR 800 per 
capita per year. Emergency department visits without 
a GP referral cost a fixed co-payment of EUR 100 per 
visit. People without a medical card pay a maximum 
of EUR 114 per month for prescription medicines per 
family. Individuals without a medical card can apply 
for a “drugs payment scheme card”, which covers 
fees exceeding this amount. All COVID-19-related 
treatment, testing and remote GP assessments during 
the pandemic were available to all residents free of 
charge.
Although VHI provides some relief from user charges, 
this is dependent on the type of plan purchased. 
For example, some plans cover some GP visit user 
charges, but most do not cover the cost of medicines 
and long-term care. Premiums have increased 
substantially over time, rising by 7-12 % a year on 
average (from EUR 671 per policy on average in 2007 
to EUR 1 048 in 2012 and EUR 1 177 in 2016). While 
46 % of the population has VHI, about 20 % has 
neither VHI nor a medical card.
Ireland faces a shortage of doctors and nurses, 
but has plans to recruit substantial numbers
Ireland has a shortage of doctors and nurses. The 
number of doctors was 3.3 per 1 000 population in 
2019 – the sixth lowest rate in the EU (Figure 9). While 
the number of nurses (12.9 per 1 000 population) was 
above the EU average (8.4), this number has declined 
in the past 10 years, and many nurses work part time. 
As a result, Ireland is increasingly reliant on recruiting 
foreign-trained doctors and nurses. Paradoxically, 
Ireland has had the highest number of medical 
graduates per capita among all EU countries in recent 
years, with about 25 new graduates per 100 000 
population each year. However, many of these medical 
graduates are international students with limited 
opportunities to complete their postgraduate training 
and practice in Ireland. 
The 2021 budget committed new funding to support 
the recruitment of up to 16 000 new staff across 
the health sector. Additionally, Sláintecare aims to 
increase the number of doctors in public hospitals 
through a public-only contracting scheme. 





Figure 9. Ireland has a relatively high number of nurses, but a relatively low number of doctors
 
Note: The EU average is unweighted. In Portugal and Greece, data refer to all doctors licensed to practise, resulting in a large overestimation of the number 
of practising doctors (e.g. of around 30 % in Portugal). In Greece, the number of nurses is underestimated as it only includes those working in hospitals. 
Source: Eurostat Database (data refer to 2019 or the nearest year).
Reforms are under way to strengthen primary 
care and address capacity issues in hospitals 
and the community
Secondary and tertiary care in Ireland are 
predominantly provided in public hospitals. The 
majority of GPs are private practitioners who provide 
care for private fee-paying patients or public patients 
with medical cards or GP visit cards when contracted 
by the government. GPs act as initial gatekeepers to 
secondary care.
Public hospitals and primary care in Ireland face 
severe capacity constraints. The number of hospital 
beds in 2019 (2.9 per 1 000 population) was the third 
lowest in the EU. Pre-COVID-19, hospitals frequently 
ran at 95 % occupancy rates – above the capacity 
considered safe. The Sláintecare reform programme 
aims to strengthen primary care and address capacity 
issues in hospitals, with record funding in the 2021 
budget committed to support this reform agenda (see 
Section 5.3).
5 Performance of the health system
5.1 Effectiveness
Ireland performs well on treatable and 
preventable causes of mortality among EU 
countries
The Irish health system fares better than those 
of many other EU countries in avoiding mortality 
from preventable and treatable causes (Figure 10). 
In Ireland, the leading causes of death that could 
be avoided through public health and prevention 
interventions are lung cancer (29 deaths per 100 000 
population, compared with 36 in the EU as a whole) 
and ischaemic heart disease (19 deaths, compared 
with 18 in the EU). The risk of developing both these 
conditions is in part related to smoking – the most 
prevalent behavioural risk factor in the country (see 
Section 3).
Mortality from treatable causes is also far below the 
EU average. The leading causes of death that could be 
avoided by timely health care interventions include 
ischaemic heart disease, colorectal cancer and breast 
cancer.
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Figure 10. Mortality rates from preventable and treatable causes are lower than the EU averages
Note: Preventable mortality is defined as death that can be mainly avoided through public health and primary prevention interventions. Treatable mortality 
is defined as death that can be mainly avoided through health care interventions, including screening and treatment. Half of all deaths for some diseases 
(e.g. ischaemic heart disease and cerebrovascular disease) are attributed to preventable mortality; the other half are attributed to treatable causes. Both 
indicators refer to premature mortality (under age 75). The data are based on the revised OECD/Eurostat lists. 
Source: Eurostat Database (data refer to 2018, except for France 2016).
Robust rollout of Sláintecare could strengthen 
the effectiveness of the health care system
Ireland’s Sláintecare reform programme (2019-28) 
aims to transform how health and social care 
services are delivered. It includes increased 
allocation of funds to support the Healthy Ireland 
initiative (running since 2013), which prioritises 
public health interventions to address the main 
drivers of preventable deaths, such as those set 
forth by the National Obesity Policy and Action 
Plan and Tobacco Free Ireland. In May 2021, the 
Sláintecare Implementation Strategy & Action Plan 
2021-23 was published (Government of Ireland, 
2021a). In September 2021, the two most senior 
people responsible for implementing Sláintecare 
resigned. The impact these resignations will have on 
Sláintecare’s implementation is unknown. 
To inform the decisions of policy makers and 
other key stakeholders, but also to improve the 
effectiveness of the health care system, Ireland 
has invested in developing an outcome-oriented 
health system performance assessment framework. 
This aims to enhance accountability and support 
monitoring of progress towards Sláintecare objectives.
Tobacco control policies have been contributing 
to reductions in smoking rates
Tobacco Free Ireland, the national tobacco control 
policy, was developed in 2013 with the aim of 
achieving a reduction in smoking prevalence to less 
than 5 % of the population by 2025. Within its scope, 
standardised (plain) packaging of all tobacco products 
was fully introduced in 2018, making Ireland one of 
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Work on drafting a Public Health Bill is ongoing. The 
proposed legislation will introduce a licensing system 
for the retail sale of tobacco and nicotine inhaling 
products and prohibit the sale of tobacco products 
to people under 18, including those available from 
self-service vending machines and mobile units, and 
at events.
More influenza vaccines were ordered in 2020, 
but uptake among older people remains a 
challenge
The influenza vaccine is administered free of charge 
for children under 17, pregnant women, health care 
workers and people aged 18 and over who have a 
medical card or GP visit card. Historically, however, 
vaccination uptake falls below the WHO target of 
75 % of people aged 65 and over, with 59 % coverage 
of this target group in the 2019/20 season. There were 
important variations in influenza vaccination uptake 
among older people across geographical regions (HSE, 
2020a) (Figure 11). Uptake among medical card and 
GP visit card holders aged 65 and over also varied 
between 38 % and 82 % among local health offices.
The COVID-19 pandemic increased the importance of 
vaccination against seasonal influenza, particularly 
for groups most at risk. For the 2020/21 influenza 
vaccination season, the HSE purchased nearly 
2 million doses, doubling the number of vaccines 
administered during the previous season. To address 
potential shortages due to demand, priority tiers were 
established, with the highest priority given to people 
aged 65 and over and health care workers.
Sláintecare aims to strengthen integrated care 
and chronic disease management
In Ireland, hospital admission rates for some chronic 
conditions such as congestive heart failure and 
diabetes are lower than the EU average (Figure 12). 
However, potentially avoidable hospital admission 
rates for asthma and COPD (378 admissions per 
100 000 population aged 15 and over) are the highest 
among EU countries. The current Sláintecare reform 
programme aims to reorient the health care system 
towards a more integrated primary and community 
care approach, while striving to empower people to 
manage their own chronic condition and care needs 
better. 
Figure 11. Seasonal influenza vaccine uptake shows 
some geographical variation
Note: Data are provisional and refer to the period of September 2019 to 
May 2020. 
Source: HSE (2020a).
Figure 12. Avoidable hospital admissions for chronic conditions are greater than in many EU countries 
Note: 1. Data for congestive heart failure are not available in Latvia and Luxembourg. 
Source: OECD Health Statistics 2021 (data refer to 2019 or nearest year).
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Five-year cancer survival rates are at least as 
high as the EU average
In Ireland, the National Screening Service runs free 
population-based screening programmes for breast, 
cervical and colorectal cancers. These programmes 
are based on a call/recall system, where eligible 
people are invited to be screened and clinical services 
are provided for further investigation and treatment 
of people identified as at risk of having or developing 
the disease.
Ireland performs as well or better than the EU average 
for five-year cancer survival rates for common 
cancers (prostate, breast, cervical, colon and lung) and 
childhood leukaemia (Figure 13).
Figure 13. Ireland performs well compared to other EU countries for five-year cancer survival rates
 
Note: Data refer to people diagnosed between 2010 and 2014. Childhood leukaemia refers to acute lymphoblastic cancer. 
Source: CONCORD Programme, London School of Hygiene and Tropical Medicine.
Ireland has an ambitious cancer strategy that is 
aligned with other ongoing programmes
The National Cancer Strategy 2017-26 builds on 
lessons learned from the previous strategy for 
cancer control, where key gaps were flagged, such as 
limited capacity and resources, insufficient support 
for cancer patients after diagnosis – including 
survivorship programmes and psychosocial services 
– and need for greater coordination and integration 
across the health care system. The Strategy aims 
to strengthen prevention and survivorship care 
programmes, establish effective clinical pathways, 
involve patients in the planning and delivery of cancer 
care, and strengthen governance and accountability 
mechanisms. The National Cancer Strategy is aligned 
with the European Commission’s Europe’s Beating 
Cancer Plan (European Commission, 2021). At the 
national level, the Strategy links to other ongoing 
programmes, such as the Healthy Ireland initiative, 
which is designed to tackle key risk factors (see 
Section 3).
The COVID-19 pandemic strongly affected 
cancer screening and treatment in Ireland
The health system was overwhelmed and many 
patients were hesitant to seek non-COVID-19 care 
during the pandemic; this may have caused a large 
number of missed diagnoses and delayed treatments. 
During the initial phases of the pandemic, many 
screening programmes in Ireland were paused, 
affecting the number of cancers detected compared to 
the same period prior to COVID-19. For example, from 
January to September 2020, there were 371 (9.5 %) 
fewer lung, breast and prostate cancer detections 
compared to the same period in 2019 (Crowley & 
Hughes, 2021). 
The effects of the pandemic were also observed on 
cancer treatments. In the first phase, a reduction of 
12.5 % (668) of cancer resections occurred relative 
to 2019, and from January to April 2020, 67 % fewer 
patients attended chemotherapy sessions in Irish 
public hospitals compared to the same period in 2019. 
At the end of August 2020, activity was still at 85 % of 
2019 levels.  
5.2 Accessibility
Unmet needs for medical care are similar to the 
EU average, but low-income groups are most 
affected
Unmet medical needs can be due to a variety of 
reasons, but in general the key drivers are those 
related to cost, waiting times or travel distance. 
In Ireland, unmet needs for medical care are 
low, according to EU-SILC survey data: 2 % of the 
population reported unmet needs for medical care 
in 2019 (Figure 14). There are gaps according to sex, 
with 2.4 % of women reporting unmet medical needs 
compared to 1.6 % of men. In addition, distribution 
of unmet care needs among income groups is 
unbalanced: the share is larger in the lowest income 
quintile (2.8 %) than the highest (0.6 %). The two 
main reasons for people in the lowest income quintile 
reporting unmet needs for medical examinations are 
waiting lists (1.6 %) and costs (1.2 %). 
Prostate cancer Childhood leukaemia Breast cancer Cervical cancer Colon cancer Lung cancer
Ireland: 91 % Ireland: 88 % Ireland: 82 % Ireland: 64 % Ireland: 61 % Ireland: 18 %
EU23: 87 % EU23: 85 % EU23: 82 % EU23: 63 % EU23: 60 % EU23: 15 %





When considering other survey instruments such as 
the European Health Interview Survey, Ireland had 
the second highest rate of unmet needs for medical 
care due to cost, waiting times or travel distance 
among EU countries in 2014, at 40.6 %, which is 
substantially higher than the EU as a whole (26.5 %). 
These differences may be explained by differences in 
the methodologies used by each instrument.
Figure 14. Unmet needs for medical care are similar 




Note: Data refer to unmet needs for a medical examination or treatment 
due to costs, distance to travel or waiting times. Caution is required in 
comparing the data across countries as there are some variations in the 
survey instrument used. 
Source: Eurostat Database, based on EU-SILC (data refer to 2019, except 
Iceland 2018).
6. The data from the Eurofound survey are not comparable to those from the EU-SILC survey because of differences in methodologies.
People in low-income groups reported lower 
unmet needs for dental care than the EU 
average
Unmet needs are greater for services that are less 
covered, such as dental care. The Department 
of Social Protection pays the full cost of one oral 
examination annually to supplement the limited 
provision of free dental treatment for medical card 
holders by the HSE. Those who do not qualify for a 
medical card need to visit a private dental provider 
and apply for tax relief on existing medical expenses 
via current tax return mechanisms, but these are only 
available for some specialised dental treatments. 
The share of people reporting unmet needs for 
dental examinations was 2.4 % in 2019, which is 
slightly lower than the 2.8 % EU average. The lowest 
income group reported the largest share, at 3.7 %, 
compared to 0.4 % among the highest income group. . 
Improvements are expected in the coming years if the 
rollout of a new national oral health policy meets its 
targets. It seeks to provide free dental care to children 
up to the age of 16 and medical card holders.
One fourth of the population were unable to 
access care when needed due to COVID-19 
The pandemic limited access to care for those 
with health conditions not related to COVID-19. 
Unmet needs for medical care because of delayed 
or missed consultations are likely to lead to poorer 
health outcomes in the future. A European-wide 
survey found that during the first 12 months of the 
pandemic, 26 % of the Irish population had forgone 
medical care, which is above the EU average of 21 % 
(Eurofound, 2021)6. 
Strong inequalities in access persist, but 
Sláintecare aims to provide universal health 
care
Ireland’s category system to determine the package 
of entitlements is reflected in a slightly narrower 
share of public spending for several health services 
and goods relative to other EU countries. Nearly 
half of the population (46 %) has private health 
insurance, which allows timely access to aspects of 
care to those who can afford it. This supplementary 
use of VHI undermines equity and efficiency in the 
health system in several ways, including through the 
presence of substantial tax subsidies that benefit 
those who are able to spend more rather than 
targeting those with lower incomes (Johnston, Thomas 
& Burke, 2020). To address these inequalities, one 
of the aims of the Sláintecare reform programme is 
the establishment of a universal, single-tier health 
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Out-of-pocket spending is mostly on primary 
care, despite initiatives to increase coverage
Ireland has a relatively low incidence of catastrophic7 
health spending: 1.2 % of Irish households 
experienced catastrophic OOP payments in 2015/16 
(latest available data). The degree of protection for 
poor households is high relative to other EU countries 
and reflects the fact that the poorest 32 % of the 
population (medical card holders) have free access 
to most health services (Johnston, Thomas & Burke, 
2020). The overall level of OOP expenditure as a share 
of total health spending is slightly lower than the 
EU average, at 11.7 % compared with 15.4 % in 2019 
(Figure 15).
7. Catastrophic expenditure is defined as household OOP spending exceeding 40 % of total household spending net of subsistence needs (i.e. food, housing and 
utilities).
More than one third of OOP expenditure goes on 
outpatient medical care (38.5 % in 2019). OOP 
spending in this category is high because GP and 
other primary care services have to be paid for (except 
by expectant mothers and individuals who qualify for 
the GP visit card based on income eligibility criteria 
– see Section 4). Other important categories of OOP 
spending in Ireland are related to long-term care 
(24 %) and pharmaceuticals (22 %). 
Ireland has one of the largest VHI markets in the 
EU, covering close to half of the population and 
accounting for 14 % of total spending on health. 
Despite its potential to reduce exposure to OOP 
spending, VHI represents a significant financial 
burden on households, accounting for around 3 % of 
household spending on average in 2015-16.
Figure 15. Outpatient medical care accounts for the largest share of out-of-pocket payments 
Note: The EU average is weighted. VHI also includes other voluntary prepayment schemes. 
Source: OECD Health Statistics 2021; Eurostat Database (data refer to 2019).
The COVID-19 pandemic supported increased 
uptake of telemedicine
The COVID-19 pandemic disrupted regular care 
delivery, presenting a challenge for providing care 
while meeting physical distancing measures. To 
overcome this, telemedicine services were increased, 
including the launch of a new secure communication 
portal (EireCare) by the HSE, linking GPs and other 
primary care providers with patients. In addition, as 
part of an emergency amendment to the Medicinal 
Products Regulation to respond to the COVID-19 
pandemic, e-prescribing became universal in the early 
weeks of the pandemic.
According to the Eurofound survey, in the first 
12 months of the pandemic in Ireland, 66 % of 
people received medicine prescriptions online or by 
telephone (compared with the EU average of 53 %), 
and 60 % received a medical consultation online or 
by telephone (versus 39 %). Patients were not charged 
for most telemedicine services during the pandemic, 
and all COVID-19-related teleconsultations with GPs 
for the whole population remained free at the point of 
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Measures have been taken to address medicine 
shortages in Ireland
Medicine shortages put patients at increased risk. In 
2018, the Health Products Regulatory Authority in 
Ireland published a medicines shortages framework 
for a multi-stakeholder approach to handle shortages 
of human medicinal products (HPRA, 2018). This 
aims to prevent shortages from occurring and to 
minimise the impact of shortages on the health 
of the population. Considering the importance of 
guaranteeing access to medicines to those who 
need it, the European Commission (2020) adopted 
a new pharmaceutical strategy for Europe. This is 
mirrored in Ireland’s National Recovery and Resilience 
Plan, which supports the rollout of a nationwide 
e-pharmacy system that will, among other things, 
monitor hospital pharmacy inventories and costs (see 
Section 5.3). 
5.3 Resilience
This section on resilience8 focuses mainly on the 
impacts of and responses to the COVID-19 pandemic. 
As noted in Section 2, the COVID-19 pandemic had a 
major impact on population health and mortality in 
Ireland in 2020 and first eight months of 2021, as in 
most other EU countries. , and the measures taken 
to contain the pandemic also affected the economy. 
Despite this, Irish GDP grew by 3.4 % in 2020 – mostly 
fuelled by the export sector (CSO, 2021).
Ireland responded to the COVID-19 pandemic 
with national and regional infection control 
measures
The first case of COVID-19 infection in Ireland was 
confirmed at the end of February 2020, and the first 
death on 11 March – the day WHO declared COVID-19 
a pandemic. By the end of August 2021, 350 000 people 
(about 7.1 % of the population) had been diagnosed 
with COVID-19 (confirmed through a laboratory test) 
– a lower rate than the EU average (8.2 %). In the same 
period, 5 100 deaths occurred among confirmed cases, 
and the death rate was about one third lower than the 
EU average.
From mid-March 2020, Ireland introduced a series 
of containment measures, starting with closures of 
schools and restrictions on large gatherings, followed 
by closures of businesses and amenities. A first 
nationwide stay-at-home order was implemented 
on 27 March, requiring the public to remain within 
2 km of home. A steady reduction in the number of 
COVID-19 cases followed (Figure 16).
8. In this context, health system resilience has been defined as the ability to prepare for, manage (absorb, adapt and transform) and learn from shocks (EU Expert 
Group on Health Systems Performance Assessment, 2020).
During summer 2020, the containment measures 
were gradually loosened, which led to a slow but 
steady rise in new cases in August 2020. Local 
outbreaks in settings such as meat processing plants 
and accommodation centres for asylum seekers led 
to geographically targeted containment measures. 
As the number of cases continued to grow, a second 
nationwide set of containment measures were 
introduced in October 2020. Measures did not include 
closing schools this time but achieved the desired 
effect of curbing COVID-19 transmission.
The relaxation of infection control measures in 
early December 2020, together with the higher 
prevalence of new variants, led to a third wave 
between December 2020 and February 2021. In the 
span of a few days, Ireland went from having one of 
the lowest COVID-19 cases per capita in the EU to the 
highest in the world, at 921 weekly cases per 100 000 
people in early January 2021. An extension of strict 
stay-at-home orders and expanded testing capacity 
helped curb the third wave by early February 2021. On 
29 April 2021, the government announced a reopening 
plan for the country throughout May and June.
During 2020 and 2021, the Irish government developed 
and made publicly available a series of COVID-19 
resilience and recovery roadmap documents. These 
were influential to COVID-19 management plans in 
other European countries. During the first wave, they 
brought some clarity to help citizens, businesses and 
health care providers plan for the medium term. 
However, over time, the success of the plans was 
limited by their multiplicity and by many changes 
made to them, exacerbating fatigue and frustration 
among citizens.





Figure 16. Ireland used three nationwide stay-at-home orders in 2020 to contain virus transmission
Notes: The EU average is unweighted (the number of countries included in the average varies depending on the week). The number of COVID-19 cases in EU 
countries was underestimated during the first wave in spring 2020 due to more limited testing. Ireland temporarily stopped testing close contacts in January 
2021, as the system could not cope with the numbers being referred. 
Sources: ECDC for COVID-19 data and authors for containment measures.
Testing capacity was scaled up, but keeping 
pace with infection rates proved challenging
Ireland successfully scaled up testing capacity and, 
by May 2020, surpassed the EU average of weekly 
number of tests performed (Figure 17). However, 
infection rates in the community during the first and 
third waves in 2020 placed the testing system under 
very significant strain to meet demand (Figure 18). 
Positivity rates from testing occasionally reached 
one in four, including in April 2020 and January 2021. 
Multiple strategies were employed to prioritise testing, 
including scaling up testing capacity, outsourcing 
laboratory processing of tests to other countries 
and temporarily limiting community testing to 
symptomatic patients only. 




Note: The EU average is weighted (the number of countries included in the average varies depending on the week). 
Source: ECDC.
Testing activity 
Note: The EU average is weighted (the number of countries included in the average varies depending on the week).
Source: ECDC.
Data extracted from ECDC on 15/03/2021 at 12:41 hrs.
Country 10/02/2020 17/02/2020 24/02/2020 02/03/2020 09/03/2020 16/03/2020 23/03/2020 30/03/2020 06/04/2020
Austria #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A 139
Belgium #N/A #N/A 1 38 86 148 236 333 464
Bulgaria #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A
Croatia 0 0 4 3 13 48 103 158 218
Cyprus #N/A #N/A #N/A 7 2 26 43 40 43
Czechia 0 0 1 7 40 116 248 399 422
Denmark 0 0 6 14 85 126 172 485 478



















European Union IrelandWeekly tests per 100 000 population
Week
30-Dec-19 6-Jan-20 13-Jan-20 20-Jan-20 27-Jan-20 3-Feb-20 10-Feb-20 17-Feb-20 24-Feb-20 2-Mar-20 9-Mar-20
30-Mar-20 6-Apr-20 13-Apr-20 20-Apr-20 27-Apr-20 4-May-20 11-May-20 18-May-20 25-May-20 1-Jun-20 8-Jun-20
29-Jun-20 6-Jul-20 13-Jul-20 20-Jul-20 27-Jul-20 3-Aug-20 10-Aug-20 17-Aug-20 24-Aug-20 31-Aug-20 7-Sep-20
28-Sep-20 5-Oct-20 12-Oct-20 19-Oct-20 26-Oct-20 2-Nov-20 9-Nov-20 16-Nov-20 23-Nov-20 30-Nov-20 7-Dec-20
28-Dec-20 4-Jan-21 11-Jan-21 18-Jan-21 25-Jan-21 1-Feb-21 8-Feb-21 15-Feb-21 22-Feb-21
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plan for the country, 
through May and June, 
announced
Testing activity 
Note: The EU average is weighted (the number of countries included in the average varies depending on the week).
Source: ECDC.
Data extracted from ECDC on 15/03/2021 at 12:41 hrs.
Country 10/02/2020 17/02/2020 24/02/2020 02/03/2020 09/03/2020 16/03/2020 23/03/2020 30/03/2020 06/04/2020
Austria #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A 139
Belgium #N/A #N/A 1 38 86 148 236 333 464
Bulgaria #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A
Croatia 0 0 4 3 13 48 103 158 218
Cyprus #N/A #N/A #N/A 7 2 26 43 40 43
Czechia 0 0 1 7 40 116 248 399 422
Denmark 0 0 6 14 85 126 172 485 478
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Week
30-D c-19 6-Jan-20 13-Jan-20 20-Jan-20 27-Jan-20 3-Feb-20 10-Feb-20 17-Feb-20 24-Feb-20 2-Mar-20 9-Mar-20
30-Mar-20 6-Apr-20 13-Apr-20 20-Apr-20 27-Apr-20 4-May-20 11-May-20 18-May-20 25-May-20 1-Jun-20 8-Jun-20
29-Jun-20 6-Jul-20 13-Jul-20 20-Jul-20 27-Jul-20 3-Aug-20 10-Aug-20 17-Aug-20 24-Aug-20 31-Aug-20 7-Sep-20
28-Sep-20 5-Oct-20 12-Oct-20 19-Oct-20 26-Oct-20 2-Nov-20 9-Nov-20 16-Nov-20 23-Nov-20 30-Nov-20 7-Dec-20
28-Dec-20 4-Jan-21 11-Jan-21 18-Jan-21 25-Jan-21 1-Feb-21 8-Feb-21 15-Feb-21 22-Feb-21





Figure 18. The first and third wave positivity rates show testing capacity shortcomings
 
 
Note: The EU average is weighted (the number of countries included in the average varies depending on the week). 
Source: ECDC.
Ireland secured a high use of its national 
contact tracing application
The national contact tracing application “Ireland 
COVID Tracker” was launched on 7 July 2020 and 
reached 1 million users (25 % of the population over 
the age of 15) within 48 hours of launching (HSE, 
2020b). By February 2021, half the Irish population 
had downloaded and were registered in the 
application. Ireland COVID Tracker also became one 
of the first national apps to be linked through the 
European interoperability gateway to apps from other 
countries (Italy and Germany), facilitating cross-
border contact tracing functionality (Government 
of Ireland, 2020a). Following its successful 
implementation, the app’s open source code was 
published, on a not-for-profit basis, for use in other 
countries.
While the successful rollout of the app provided 
a complementary addition to the contact tracing 
programme, follow-up of suspected contacts, contact 
management and arrangement of testing struggled to 
keep pace with demand during peaks of infection. The 
Irish public health workforce has traditionally been 
under-resourced, so a separate programme was set 
up to conduct routine contact tracing. This, at times, 
caused some difficulties in carrying out effective 
tracing of more complex cases. 
Ireland used recruitment initiatives to ensure 
an adequate health workforce during the 
pandemic
The Irish government took a number of actions to 
maintain and scale up health workforce capacity to 
respond to the pandemic. Most notably, the number 
of HSE full-time employees increased from 119 000 
to 130 000 between January 2019 and July 2021. Other 
recruitment initiatives included increasing the hours 
of part-time staff, maximising agency usage, rehiring 
retired clinicians, redeploying staff and encouraging 
those on career breaks to return early (Kennelly et al., 
2020). 
Ireland’s vaccination programme has 
significantly reduced mortality caused by 
COVID-19
Following approval of the first vaccines against 
COVID-19 in late-2020, the vaccination programme 
started in Ireland on 29 December (HSE, 2021a). 
Initially, vaccine rollout prioritised vulnerable groups 
through cohort-based vaccination plans, using an 
age-based approach. By the end of August 2021, over 
6.8 million vaccine doses had been administered 
(Figure 19), with almost 70 % of the total population 
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Figure 19. Ireland’s COVID-19 vaccination rates are higher than the EU average 
 
Note: The EU average is unweighted (the number of countries used for the average varies depending on the week). 
Sources: ECDC for COVID-19 cases and Our World In Data for vaccination rates.
The pandemic led to health information system 
developments, but a ransomware attack caused 
disruption
Surveillance of COVID-19 cases was integrated into 
Ireland’s existing national computerised infectious 
disease reporting system. While the pandemic 
accelerated developments to the national health 
information system, the permanence of these changes 
remains unclear. For example, the unique patient 
identifier was introduced to monitor COVID-19 
patients and assigned to everyone who tested for 
COVID-19 and received a vaccination. An emergency 
data hub for researchers to access data about 
COVID-19 was also developed, through which data 
from the Central Statistics Office can be accessed. 
Also, acute care COVID-19 data were made available 
on a highly granular level to health care providers 
and researchers (HRB, 2021; Government of Ireland, 
2020b).
On 14 May 2021, the HSE suffered a major 
ransomware cyberattack that caused all its 
information systems to stop operating nationwide. 
The attack also resulted in leaks of confidential 
medical records and corporate documents. The 
incident caused serious disruption to the functioning 
of the health care system in general, including its 
COVID-19 operations (HSE, 2021c).
Ireland’s National Recovery and Resilience Plan 
2021 paves the way for a sustainable recovery 
Following the announcement of the European 
Commission’s Recovery and Resilience Facility 
recovery package, on 1 June 2021, the Government of 
Ireland (2021b) published the National Recovery and 
Resilience Plan 2021. It focuses on 16 investments 
and 9 reform commitments, with a value of just 
under EUR 1 billion, until 2026. The plan aims to 
advance green transition, accelerate and expand 
digital reforms and focus on social and economic 
recovery and job creation. One of the priorities 
includes developing the strategic health care reform 
agenda set out under Sláintecare, by “committing to 
the implementation of initiatives which will improve 
access to care in the community and begin the 
process of removing private health care from public 
hospitals”. In addition, EUR 75 million is committed 
to investments in e-health (digitalisation of hospital 
management information systems and e-pharmacy).
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• Life expectancy in Ireland is higher than in 
most other EU countries, having reached 
82.8 years in 2019. Up to the end of August 
2021, COVID-19 accounted for 5 100 deaths, a 
death rate about one third lower than the EU 
average.
• While most Irish people report being in good 
health, nearly three in ten suffer from a 
chronic condition. The incidence of cancer in 
Ireland is higher than the EU average, with 
prostate cancer among men and breast cancer 
among women the leading causes. Over 
31 000 people died from cancer in 2018. The 
COVID-19 pandemic had at least a temporary 
dampening effect on screening and early 
detection of cancers.
• Risk factors for health – notably smoking and 
alcohol consumption – are important drivers 
of mortality in Ireland. While progress has 
been made in reducing smoking rates among 
adults, regular heavy alcohol consumption 
among adults is higher than in most EU 
countries and obesity is now higher than the 
EU average.
• Per capita health spending in Ireland was 
EUR 3 513 in 2019 (adjusted for purchasing 
power), which is close to the EU average. The 
proportion of expenditure from voluntary 
health insurance schemes was 14 % – the 
second highest in the EU, and almost three 
times higher than the EU average  (5 %). 
• Ireland faces a shortage of doctors and 
nurses, which contributes to long waiting 
times for publicly funded services and 
increased demand for private providers. The 
implementation of the Sláintecare consultant 
contract by 2021 aims to address a shortage of 
doctors in public hospitals, while contributing 
towards universal health care.
• In general, Ireland fares better than many 
EU countries on avoiding deaths from both 
treatable and preventable causes. Further 
efforts, however, are needed to reduce 
the burden of cancer. The Healthy Ireland 
initiative and the National Cancer Strategy 
aim to improve cancer prevention and care.
• The pandemic contributed to limiting access 
to care for those with conditions not related 
to COVID-19. During the first 12 months of 
the pandemic, 26 % of the Irish population 
reported that they did not receive a medical 
examination or needed treatment, a slightly 
higher proportion than the EU average (21 %). 
The digitalisation of the health care system 
aimed to mitigate disruptions to regular care, 
with increased uptake of telemedicine and 
electronic medicine prescriptions.
• Despite Ireland’s successful handling of the 
first two waves of the COVID-19 pandemic in 
early 2020, the country experienced a severe 
third wave in late 2020 and early 2021, due to 
a relaxation of containment measures and 
the spread of more transmissible variants. 
This created unprecedented pressure on 
the contact tracing system. The third wave 
underscored the importance of an integrated, 
staggered response, informed by evidence-
based guidance including testing and contact 
tracing. 
• As of the end of August 2021, Ireland’s 
vaccination programme had achieved better 
rates than the EU average, with almost 70 % 
of the population receiving two doses (or 
equivalent). The increase in vaccination was 
accompanied by a significant reduction in 
COVID-19 deaths.
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